Loading clinical trials...
Loading clinical trials...
Evaluation of Mepolizumab Effectiveness in Patients With Chronic Rhinosinusitis With Nasal Polyps and Comorbid Severe Eosinophilic Asthma: an Integrative Multi-omics Approach to Assess Biomarker Signatures of Responsive Disease Endotypes
Conditions
Interventions
Mepolizumab 100 MG
Locations
2
Greece
Pulmonary Dept First ICU, Evagelismos Hospital
Athens, Attica, Greece
Pulmonary Dept First ICU Evangelismos Hospital
Athens, Greece
Start Date
September 1, 2023
Primary Completion Date
August 31, 2026
Completion Date
March 30, 2027
Last Updated
April 17, 2026
NCT06914908
NCT05246267
NCT07125586
NCT06118554
NCT05708300
NCT07424144
Lead Sponsor
National and Kapodistrian University of Athens
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions